In the News December 12, 2016

Science | Under 21st Century Cures Legislation, Stem Cell Advocates Expect Regulatory Shortcuts

Marc Scheineson comments on the new Cures Act directing the U.S. Food and Drug Administration to approve drugs and devices with greater urgency.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222
This website uses cookies to improve functionality and performance. By continuing to browse this site, you are consenting to the use of cookies on this website. For details, see our Privacy Statement